Feasibility of Group-Based Metacognitive Therapy for PTSD

Condition(s) studied

Investigational drug(s) / intervention(s)

Group-based metacognitive therapy: Group-based metacognitive therapy will be offered for 14 weeks.

Study summary

The primary objective of this study is to investigate the feasibility and acceptability of group-based Metacognitive Therapy (MCT) for post-traumatic stress disorder (PTSD) when delivered within routine psychiatric care in Sweden.

The secondary objective is to evaluate preliminary treatment effects of group-based MCT on symptoms of post-traumatic stress, complex PTSD, depression, and quality of life, and to compare treatment dropout rates to those reported in the existing literature on exposure-based treatments for PTSD.

Eligibility

Primary outcome measure(s)

• The proportion of participants that conducts the weekly measures and further assessment points — Through study completion up to the 6 months follow up
  The proportion of participants that conducts the weekly measures and further assessment points
• The proportion of participants that go through the entire treatment period — Completion of treatment period, up to the last session delivered 14 weeks after treatment start
  The proportion of participants that go through the entire treatment period
• Adverse events related to the treatment — Through study completion, up to the 6 months follow up
  Adverse events related to the treatment
• Acceptability — Completion of treatment period, up to the last session delivered 14 weeks after treatment start
  Number of drop-outs from treatment
• Treatment acceptability — Baseline
  Number of individuals offered the intervention but declined part of treatment
• Treatment acceptability — Up to 6 months after treatment completion
  Participants experience/satisfaction with treatment and assessment procedures through qualitative interviews
• Participants satisfaction with treatment, assessed by The Client Satisfaction Questionnaire (CSQ-8). — Up till treatment completion, 14 weeks after treatment start
  The CSQ-8 yields a single score measuring a single dimension of overall satisfaction. An "overall score" is calculated by summing the score on each of the eight scale item. Scores range from 8 to 32, with higher values indicating higher satisfaction.
• Treatment adherence — Up to treatment completion, 14 weeks after treatment start.
  The proportion of completed group-sessions

Trial sites (1)

More Karolinska Institutet trials in Sweden

Other trials for the same condition